CIK 0001651308 · Large accelerated filer
BeOne Medicines Ltd.
Sign in to watch- Ticker
- BEIGF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981209416
- Phone
- 41-616851900
- Business address
- C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
- Former names
- BeiGene, Ltd.
Securities
- ONC American Depositary Shares Nasdaq
- BEIGF Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $48,487,541
- in 9 filings, $47.8M under 10b5-1 plans
Net −$48,487,541. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-12-15 | Wang Xiaodong Director | Gift | −165,295 | 5,703,162 | ||
| 2020-12-15 | AMGEN INC 10% owner | Grant or award | +67,941 | $239.31 | $16.3M | 18,592,314 |
| 2020-12-14 | Liang Howard CFO & Chief Strategy Officer | Option exercise | +1,405,300 | $0.50 | $703K | 1,573,715 |
| 2020-12-14 | Liang Howard CFO & Chief Strategy Officer | Option exercise | +91,900 | $6.50 | $597K | 91,900 |
| 2020-12-14 | Liang Howard CFO & Chief Strategy Officer | Sale | −4,100 | $225.24 | $923K | 87,800 |
| 2020-12-14 | Liang Howard CFO & Chief Strategy Officer | Sale | −6,203 | $226.40 | $1.4M | 81,597 |
| 2020-12-14 | Liang Howard CFO & Chief Strategy Officer | Sale | −15,062 | $227.08 | $3.4M | 66,535 |
| 2020-12-14 | Liang Howard CFO & Chief Strategy Officer | Sale | −7,500 | $227.72 | $1.7M | 59,035 |
| 2020-12-14 | Liang Howard CFO & Chief Strategy Officer | Sale | −400 | $228.10 | $91K | 58,635 |
| 2020-12-14 | Liang Howard CFO & Chief Strategy Officer | Sale | −5,885 | $228.23 | $1.3M | 52,750 |
| 2020-12-14 | Liang Howard CFO & Chief Strategy Officer | Sale | −9,752 | $229.18 | $2.2M | 42,998 |
| 2020-12-14 | Liang Howard CFO & Chief Strategy Officer | Sale | −24,842 | $230.51 | $5.7M | 18,156 |
| 2020-12-14 | Liang Howard CFO & Chief Strategy Officer | Sale | −17,456 | $231.11 | $4.0M | 700 |
| 2020-12-14 | Liang Howard CFO & Chief Strategy Officer | Sale | −700 | $232.19 | $163K | 0 |
| 2020-12-14 | Liang Howard CFO & Chief Strategy Officer | Option exercise · Stock Option (Right to Buy) | −2,600,000 | 831,000 | ||
| 2020-12-11 | OYLER JOHN Chief Executive Officer | Gift | −1,591,317 | 7,336,253 | ||
| 2020-12-11 | OYLER JOHN Chief Executive Officer | Gift | −545,597 | 6,790,656 | ||
| 2020-12-11 | OYLER JOHN Chief Executive Officer | Gift | +545,597 | 545,597 | ||
| 2020-12-10 | Wang Xiaodong Director | Gift | −88,010 | 7,112,999 | ||
| 2020-12-10 | Wang Xiaodong Director | Gift | −1,244,542 | 5,868,457 |
Page 75 of 99 · 1,972 trades